Form 4 CULLEN/FROST BANKERS, For: Oct 29 Filed by: Wilson Kenneth L.
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form SC 13D/A PIMCO Flexible Real Esta Filed by: IVASCYN DANIEL J
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 16)*
PIMCO Flexible Real Estate Income Fund
(Name of Issuer)
Institutional Class Common Shares
(Title of Class of Securities)
72203N509
(CUSIP Number)
Daniel J. Ivascyn
c/o Pacific Investment
Management Company
LLC
650 Newport Center Drive
Newport Beach, California 92660
Copy to:
Regina... (continue reading...)
Form 4 TheRealReal, Inc. For: Oct 29 Filed by: Sahi Levesque Rati
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 4 Quanterix Corp For: Oct 31 Filed by: Toloue Masoud
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form SC 13D/A Amneal Pharmaceuticals, Filed by: Patel Chirag K.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 5)*
Amneal Pharmaceuticals, Inc.
(Name of Issuer)
Class A Common Stock, par value $0.01
... (continue reading...)
More SEC Filings
View Older Stories-
Form 4 Zoom Video Communication For: Oct 29 Filed by: Chadwick Jonathan
-
Form 4 CULLEN/FROST BANKERS, For: Oct 29 Filed by: Rhodes Coolidge E JR
-
Form 4 Focus Impact Acquisition For: Oct 29 Filed by: Focus Impact Sponsor, LLC
-
Form 4 CULLEN/FROST BANKERS, For: Oct 29 Filed by: Salinas Jerry
-
Form SC 13D/A 374Water Inc. Filed by: Nagar Yaacov
-
Form 4 CULLEN/FROST BANKERS, For: Oct 29 Filed by: Severyn Carol Jean
-
Form 4 CULLEN/FROST BANKERS, For: Oct 29 Filed by: Bracher Paul
-
Form 4 CULLEN/FROST BANKERS, For: Oct 29 Filed by: Berman Bobby
-
Form 4 CULLEN/FROST BANKERS, For: Oct 29 Filed by: Alonzo Annette M
-
Form 4 CULLEN/FROST BANKERS, For: Oct 29 Filed by: Stead Jimmy
-
Form 4 COLUMBIA BANKING SYSTEM, For: Oct 30 Filed by: MACHUCA LUIS
-
Form 144 NASDAQ, INC. Filed by: Tal Cohen
-
Form 4 CULLEN/FROST BANKERS, For: Oct 29 Filed by: Wolfshohl Candace K
-
Form 4 DROPBOX, INC. For: Oct 29 Filed by: Regan Timothy
-
Form SC 13D/A LEAP THERAPEUTICS, INC. Filed by: BeiGene, Ltd.
-
Form 4 Inari Medical, Inc. For: Oct 29 Filed by: Hykes Andrew
-
Form SC 13D/A LEE ENTERPRISES, Inc Filed by: Jerrilyn M Hoffmann Revocable Trust dated May 30, 2001
-
Form 4 CULLEN/FROST BANKERS, For: Oct 29 Filed by: Kasanoff Howard L.
-
Form 4 GLOBE LIFE INC. For: Oct 30 Filed by: MITCHELL ROBERT BRIAN
-
Form 4 CULLEN/FROST BANKERS, For: Oct 29 Filed by: GREEN PHILLIP D
-
Form 4 Paycom Software, Inc. For: Oct 30 Filed by: Richison Chad R.
-
Form 4 Inari Medical, Inc. For: Oct 29 Filed by: Hoffman William
-
Form 4 Meta Platforms, Inc. For: Oct 29 Filed by: Newstead Jennifer
-
Form 4 Grocery Outlet Holding For: Oct 30 Filed by: Lindberg Eric J. Jr.
-
Form 4 Udemy, Inc. For: Oct 29 Filed by: Brown Gregory Scott
-
Form S-3MEF ASP Isotopes Inc.
-
Form 4 SECURITY NATIONAL FINANC For: Oct 30 Filed by: Quist Adam George
-
Form 4 Alignment Healthcare, For: Oct 29 Filed by: Freeman Robert Thomas
-
Form 144/A Baker Hughes Co Filed by: Buese Nancy
-
Form 144 AMERIPRISE FINANCIAL Filed by: Alvero Gumer
-
Form X-17A-5 PORTSMOUTH FINANCIAL For: Jun 30
-
Form 4 RECURSION PHARMACEUTICAL For: Oct 29 Filed by: Borgeson Blake
-
Form SC 13G Lyell Immunopharma, Inc. Filed by: Foresite Capital Fund IV, L.P.
-
Form 4/A JOHNSON & JOHNSON For: May 01 Filed by: REED JOHN C
-
Form 4 LAS VEGAS SANDS CORP For: Oct 29 Filed by: Goldstein Robert G
-
Form 4 Third Harmonic Bio, Inc. For: Oct 29 Filed by: BVF II GP LLC
-
Form 4 Eledon Pharmaceuticals, For: Oct 29 Filed by: BVF I GP LLC
-
Form SC 13G/A Eledon Pharmaceuticals, Filed by: BIOTECHNOLOGY VALUE FUND L P
-
Form SC 13G/A Eledon Pharmaceuticals, Filed by: BIOTECHNOLOGY VALUE FUND L P
-
Form 144 BRUNSWICK CORP Filed by: FOULKES DAVID M
-
Form SC 13G Apyx Medical Corp Filed by: Archon Capital Management LLC
-
Form SCHEDULE 13D/A LEAP THERAPEUTICS, INC. Filed by: BeiGene, Ltd.
-
Form 4 PARKERVISION INC For: Oct 29 Filed by: ROSENBAUM PAUL A
-
Form 4 Atlas Energy Solutions For: Oct 29 Filed by: Leveille Brian Anthony
-
Form 4 LendingClub Corp For: Oct 29 Filed by: Morris John C.
-
Form 4 MDU RESOURCES GROUP INC For: Oct 31 Filed by: SPARBY DAVID M
-
Form SC 13D/A BigBear.ai Holdings, Filed by: BBAI Ultimate Holdings, LLC
-
Form 4 Overland Advantage For: Oct 29 Filed by: Platinum International Investment Holding RSC Ltd
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 CITIGROUP INC